1-20 of 23
Andrew D. Weinberg
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

PD-1 and ICOS co-expression identifies tumor-reactive CD4 Th cells in human solid tumors

Free
Thomas Duhen, Rebekka Duhen, Olivier Fesneau, Kimberly Samson, Alexandra Frye, Michael Beymer, Venkatesh Rajamanickam, Eric Tran, Brady Bernard, Andrew D Weinberg
Journal: The Journal of Immunology
J Immunol (2022) 208 (1_Supplement): 117.02.
https://doi.org/10.4049/jimmunol.208.Supp.117.02
Published: 01 May 2022
View articletitled, PD-1 and ICOS co-expression identifies tumor-reactive CD4 Th cells in human solid tumors
Add to Citation Manager for PD-1 and ICOS co-expression identifies tumor-reactive CD4 Th cells in human solid tumors
Journal Articles

Enriching for tumor-reactive CD8 TIL (AGX148) leads to effective tumor clearance in a patient-derived xenograph model

Free
Colin J Thalhofer, Elaine A Ballinger, Ryan D Montler, Nicholas P Morris, Joshua F Rios, Tarsem Moudgil, Andrew D Weinberg
Journal: The Journal of Immunology
J Immunol (2022) 208 (1_Supplement): 117.06.
https://doi.org/10.4049/jimmunol.208.Supp.117.06
Published: 01 May 2022
View articletitled, Enriching for tumor-reactive CD8 TIL (AGX148) leads to effective tumor clearance in a patient-derived xenograph model
Add to Citation Manager for Enriching for tumor-reactive CD8 TIL (AGX148) leads to effective tumor clearance in a patient-derived xenograph model
Journal Articles

OX40 boosts and sustains humoral and cellular immune responses to SARS-CoV2 spike protein and RNA vaccinations

Free
Rebekka A Duhen, Michael Beymer, Shawn Jensen, Srinivas Abbina, Suraj Abraham, Anitha Thomas, Hong-Ming Hu, Bernard A Fox, Andrew D Weinberg
Journal: The Journal of Immunology
J Immunol (2022) 208 (1_Supplement): 65.14.
https://doi.org/10.4049/jimmunol.208.Supp.65.14
Published: 01 May 2022
View articletitled, OX40 boosts and sustains humoral and cellular immune responses to SARS-CoV2 spike protein and RNA vaccinations
Add to Citation Manager for OX40 boosts and sustains humoral and cellular immune responses to SARS-CoV2 spike protein and RNA vaccinations
Journal Articles

Evaluating the Potential of Harnessing Anti-Leukemia T cells for Treating T-ALL

Free
Todd A Triplett, Joshua Rios, Srividya Kottapalli, Andrew D Weinberg, Alexander Somma, Trevor Sandoval
Journal: The Journal of Immunology
J Immunol (2021) 206 (1_Supplement): 67.23.
https://doi.org/10.4049/jimmunol.206.Supp.67.23
Published: 01 May 2021
View articletitled, Evaluating the Potential of Harnessing Anti-Leukemia T cells for Treating T-ALL
Add to Citation Manager for Evaluating the Potential of Harnessing Anti-Leukemia T cells for Treating T-ALL
Journal Articles

OX40 Agonist Tumor Immunotherapy Does Not Impact Regulatory T Cell Suppressive Function

Free
Fanny Polesso, Minhaz Sarker, Andrew D. Weinberg, Susan E. Murray, Amy E. Moran
Journal: The Journal of Immunology
J Immunol (2019) 203 (7): 2011–2019.
https://doi.org/10.4049/jimmunol.1900696
Published: 01 October 2019
View articletitled, OX40 Agonist Tumor Immunotherapy Does Not Impact Regulatory T Cell Suppressive Function
Open the PDF for OX40 Agonist Tumor Immunotherapy Does Not Impact Regulatory T Cell Suppressive Function in another window
Add to Citation Manager for OX40 Agonist Tumor Immunotherapy Does Not Impact Regulatory T Cell Suppressive Function
Includes: Supplementary data
Journal Articles

Neoadjuvant OX40 therapy in patients with head and neck cancer induces profound changes in tumor-infiltrating lymphocytes

Free
Rebekka A. Duhen, Carmen Ballesteros-Merino, R. Bryan Bell, Rom Leidner, Yoshinobu Koguchi, Carlo Bifulco, Bernard A. Fox, Andrew D. Weinberg
Journal: The Journal of Immunology
J Immunol (2018) 200 (1_Supplement): 57.40.
https://doi.org/10.4049/jimmunol.200.Supp.57.40
Published: 01 May 2018
View articletitled, Neoadjuvant OX40 therapy in patients with head and neck cancer induces profound changes in tumor-infiltrating lymphocytes
Add to Citation Manager for Neoadjuvant OX40 therapy in patients with head and neck cancer induces profound changes in tumor-infiltrating lymphocytes
Journal Articles

Immunotherapy Expands and Maintains the Function of High-Affinity Tumor-Infiltrating CD8 T Cells In Situ

Free
Amy E. Moran, Fanny Polesso, Andrew D. Weinberg
Journal: The Journal of Immunology
J Immunol (2016) 197 (6): 2509–2521.
https://doi.org/10.4049/jimmunol.1502659
Published: 15 September 2016
View articletitled, Immunotherapy Expands and Maintains the Function of High-Affinity Tumor-Infiltrating CD8 T Cells In Situ
Open the PDF for Immunotherapy Expands and Maintains the Function of High-Affinity Tumor-Infiltrating CD8 T Cells In Situ in another window
Add to Citation Manager for Immunotherapy Expands and Maintains the Function of High-Affinity Tumor-Infiltrating CD8 T Cells In Situ
Journal Articles

OX40 Ligand Regulates Inflammation and Mortality in the Innate Immune Response to Sepsis

Free
Matthew Karulf, Ann Kelly, Andrew D. Weinberg, Jeffrey A. Gold
Journal: The Journal of Immunology
J Immunol (2010) 185 (8): 4856–4862.
https://doi.org/10.4049/jimmunol.1000404
Published: 15 October 2010
View articletitled, OX40 Ligand Regulates Inflammation and Mortality in the Innate Immune Response to Sepsis
Open the PDF for OX40 Ligand Regulates Inflammation and Mortality in the Innate Immune Response to Sepsis in another window
Add to Citation Manager for OX40 Ligand Regulates Inflammation and Mortality in the Innate Immune Response to Sepsis
Includes: Supplementary data
Journal Articles

Cutting Edge: OX40 Agonists Can Drive Regulatory T Cell Expansion if the Cytokine Milieu Is Right

Free
Carl E. Ruby, Melissa A. Yates, Daniel Hirschhorn-Cymerman, Peter Chlebeck, Jedd D. Wolchok, Alan N. Houghton, Halina Offner, Andrew D. Weinberg
Journal: The Journal of Immunology
J Immunol (2009) 183 (8): 4853–4857.
https://doi.org/10.4049/jimmunol.0901112
Published: 15 October 2009
View articletitled, Cutting Edge: OX40 Agonists Can Drive Regulatory T Cell Expansion if the Cytokine Milieu Is Right
Open the PDF for Cutting Edge: OX40 Agonists Can Drive Regulatory T Cell Expansion if the Cytokine Milieu Is Right in another window
Add to Citation Manager for Cutting Edge: OX40 Agonists Can Drive Regulatory T Cell Expansion if the Cytokine Milieu Is Right
Journal Articles

OX40-Enhanced Tumor Rejection and Effector T Cell Differentiation Decreases with Age

Free
Carl E. Ruby, Andrew D. Weinberg
Journal: The Journal of Immunology
J Immunol (2009) 182 (3): 1481–1489.
https://doi.org/10.4049/jimmunol.182.3.1481
Published: 01 February 2009
View articletitled, OX40-Enhanced Tumor Rejection and Effector T Cell Differentiation Decreases with Age
Open the PDF for OX40-Enhanced Tumor Rejection and Effector T Cell Differentiation Decreases with Age in another window
Add to Citation Manager for OX40-Enhanced Tumor Rejection and Effector T Cell Differentiation Decreases with Age
Journal Articles

IL-12 Is Required for Anti-OX40-Mediated CD4 T Cell Survival

Free
Carl E. Ruby, Ryan Montler, Rongxui Zheng, Suyu Shu, Andrew D. Weinberg
Journal: The Journal of Immunology
J Immunol (2008) 180 (4): 2140–2148.
https://doi.org/10.4049/jimmunol.180.4.2140
Published: 15 February 2008
View articletitled, IL-12 Is Required for Anti-OX40-Mediated CD4 T Cell Survival
Open the PDF for IL-12 Is Required for Anti-OX40-Mediated CD4 T Cell Survival in another window
Add to Citation Manager for IL-12 Is Required for Anti-OX40-Mediated CD4 T Cell Survival
Journal Articles

Defects in the Acquisition of CD8 T Cell Effector Function after Priming with Tumor or Soluble Antigen Can Be Overcome by the Addition of an OX40 Agonist

Free
William L. Redmond, Michael J. Gough, Bridget Charbonneau, Timothy L. Ratliff, Andrew D. Weinberg
Journal: The Journal of Immunology
J Immunol (2007) 179 (11): 7244–7253.
https://doi.org/10.4049/jimmunol.179.11.7244
Published: 01 December 2007
View articletitled, Defects in the Acquisition of CD8 T Cell Effector Function after Priming with Tumor or Soluble Antigen Can Be Overcome by the Addition of an OX40 Agonist
Open the PDF for Defects in the Acquisition of CD8 T Cell Effector Function after Priming with Tumor or Soluble Antigen Can Be Overcome by the Addition of an OX40 Agonist in another window
Add to Citation Manager for Defects in the Acquisition of CD8 T Cell Effector Function after Priming with Tumor or Soluble Antigen Can Be Overcome by the Addition of an OX40 Agonist
Journal Articles

OX40-Mediated Differentiation to Effector Function Requires IL-2 Receptor Signaling but Not CD28, CD40, IL-12Rβ2, or T-bet

Free
Cortny A. Williams, Susan E. Murray, Andrew D. Weinberg, David C. Parker
Journal: The Journal of Immunology
J Immunol (2007) 178 (12): 7694–7702.
https://doi.org/10.4049/jimmunol.178.12.7694
Published: 15 June 2007
View articletitled, OX40-Mediated Differentiation to Effector Function Requires IL-2 Receptor Signaling but Not CD28, CD40, IL-12Rβ2, or T-bet
Open the PDF for OX40-Mediated Differentiation to Effector Function Requires IL-2 Receptor Signaling but Not CD28, CD40, IL-12Rβ2, or T-bet in another window
Add to Citation Manager for OX40-Mediated Differentiation to Effector Function Requires IL-2 Receptor Signaling but Not CD28, CD40, IL-12Rβ2, or T-bet
Journal Articles

IL-18 Bridges Innate and Adaptive Immunity through IFN-γ and the CD134 Pathway

Free
Joseph R. Maxwell, Rajwardhan Yadav, Robert J. Rossi, Carl E. Ruby, Andrew D. Weinberg, Hector L. Aguila, Anthony T. Vella
Journal: The Journal of Immunology
J Immunol (2006) 177 (1): 234–245.
https://doi.org/10.4049/jimmunol.177.1.234
Published: 01 July 2006
View articletitled, IL-18 Bridges Innate and Adaptive Immunity through IFN-γ and the CD134 Pathway
Open the PDF for IL-18 Bridges Innate and Adaptive Immunity through IFN-γ and the CD134 Pathway in another window
Add to Citation Manager for IL-18 Bridges Innate and Adaptive Immunity through IFN-γ and the CD134 Pathway
Journal Articles

Activation Pathways Implicate Anti-HLA-DP and Anti-LFA-1 Antibodies as Lead Candidates for Intervention in Chronic Berylliosis

Free
Yuan K. Chou, David M. Edwards, Andrew D. Weinberg, Arthur A. Vandenbark, Brian L. Kotzin, Andrew P. Fontenot, Gregory G. Burrows
Journal: The Journal of Immunology
J Immunol (2005) 174 (7): 4316–4324.
https://doi.org/10.4049/jimmunol.174.7.4316
Published: 01 April 2005
View articletitled, Activation Pathways Implicate Anti-HLA-DP and Anti-LFA-1 Antibodies as Lead Candidates for Intervention in Chronic Berylliosis
Open the PDF for Activation Pathways Implicate Anti-HLA-DP and Anti-LFA-1 Antibodies as Lead Candidates for Intervention in Chronic Berylliosis in another window
Add to Citation Manager for Activation Pathways Implicate Anti-HLA-DP and Anti-LFA-1 Antibodies as Lead Candidates for Intervention in Chronic Berylliosis
Journal Articles

A Signal through OX40 (CD134) Allows Anergic, Autoreactive T Cells to Acquire Effector Cell Functions

Free
Stephanie K. Lathrop, Cortny A. Huddleston, Per A. Dullforce, Megan J. Montfort, Andrew D. Weinberg, David C. Parker
Journal: The Journal of Immunology
J Immunol (2004) 172 (11): 6735–6743.
https://doi.org/10.4049/jimmunol.172.11.6735
Published: 01 June 2004
View articletitled, A Signal through OX40 (CD134) Allows Anergic, Autoreactive T Cells to Acquire Effector Cell Functions
Open the PDF for A Signal through OX40 (CD134) Allows Anergic, Autoreactive T Cells to Acquire Effector Cell Functions in another window
Add to Citation Manager for A Signal through OX40 (CD134) Allows Anergic, Autoreactive T Cells to Acquire Effector Cell Functions
Journal Articles

OX40-Mediated Memory T Cell Generation Is TNF Receptor-Associated Factor 2 Dependent

Free
Rodney A. Prell, Dean E. Evans, Colin Thalhofer, Tom Shi, Castle Funatake, Andrew D. Weinberg
Journal: The Journal of Immunology
J Immunol (2003) 171 (11): 5997–6005.
https://doi.org/10.4049/jimmunol.171.11.5997
Published: 01 December 2003
View articletitled, OX40-Mediated Memory T Cell Generation Is TNF Receptor-Associated Factor 2 Dependent
Open the PDF for OX40-Mediated Memory T Cell Generation Is TNF Receptor-Associated Factor 2 Dependent in another window
Add to Citation Manager for OX40-Mediated Memory T Cell Generation Is TNF Receptor-Associated Factor 2 Dependent
Journal Articles

Engagement of OX40 Enhances Antigen-Specific CD4+ T Cell Mobilization/Memory Development and Humoral Immunity: Comparison of αOX-40 with αCTLA-4

Free
Dean E. Evans, Rodney A. Prell, Colin J. Thalhofer, Arthur A. Hurwitz, Andrew D. Weinberg
Journal: The Journal of Immunology
J Immunol (2001) 167 (12): 6804–6811.
https://doi.org/10.4049/jimmunol.167.12.6804
Published: 15 December 2001
View articletitled, Engagement of OX40 Enhances Antigen-Specific CD4+ T Cell Mobilization/Memory Development and Humoral Immunity: Comparison of αOX-40 with αCTLA-4
Open the PDF for Engagement of OX40 Enhances Antigen-Specific CD4+ T Cell Mobilization/Memory Development and Humoral Immunity: Comparison of αOX-40 with αCTLA-4 in another window
Add to Citation Manager for Engagement of OX40 Enhances Antigen-Specific CD4+ T Cell Mobilization/Memory Development and Humoral Immunity: Comparison of αOX-40 with αCTLA-4
Journal Articles

Augmentation Versus Inhibition: Effects of Conjunctional OX-40 Receptor Monoclonal Antibody and IL-2 Treatment on Adoptive Immunotherapy of Advanced Tumor

Free
Jørgen Kjaergaard, Liaomin Peng, Peter A. Cohen, Judith A. Drazba, Andrew D. Weinberg, Suyu Shu
Journal: The Journal of Immunology
J Immunol (2001) 167 (11): 6669–6677.
https://doi.org/10.4049/jimmunol.167.11.6669
Published: 01 December 2001
View articletitled, Augmentation Versus Inhibition: Effects of Conjunctional OX-40 Receptor Monoclonal Antibody and IL-2 Treatment on Adoptive Immunotherapy of Advanced Tumor
Open the PDF for Augmentation Versus Inhibition: Effects of Conjunctional OX-40 Receptor Monoclonal Antibody and IL-2 Treatment on Adoptive Immunotherapy of Advanced Tumor in another window
Add to Citation Manager for Augmentation Versus Inhibition: Effects of Conjunctional OX-40 Receptor Monoclonal Antibody and IL-2 Treatment on Adoptive Immunotherapy of Advanced Tumor
Journal Articles

The OX40 Costimulatory Receptor Determines the Development of CD4 Memory by Regulating Primary Clonal Expansion

Free
Irene Gramaglia, Amha Jember, Susanne D. Pippig, Andrew D. Weinberg, Nigel Killeen, Michael Croft
Journal: The Journal of Immunology
J Immunol (2000) 165 (6): 3043–3050.
https://doi.org/10.4049/jimmunol.165.6.3043
Published: 15 September 2000
View articletitled, The OX40 Costimulatory Receptor Determines the Development of CD4 Memory by Regulating Primary Clonal Expansion
Open the PDF for The OX40 Costimulatory Receptor Determines the Development of CD4 Memory by Regulating Primary Clonal Expansion in another window
Add to Citation Manager for The OX40 Costimulatory Receptor Determines the Development of CD4 Memory by Regulating Primary Clonal Expansion